Bright Bodies Program for Childhood Obesity
Trial Summary
What is the purpose of this trial?
This study will evaluate the effectiveness of the Bright Bodies intervention in improving body mass index (BMI) among 7-13 year-old children with obesity simultaneously with the impact of the implementation strategy on adoption, reach, fidelity, cost, and maintenance of the intervention in three heterogenous settings serving patients disproportionately affected by obesity.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the Bright Bodies treatment for childhood obesity?
Is the Bright Bodies Program for Childhood Obesity safe for children?
How is the Bright Bodies treatment for childhood obesity different from other treatments?
Research Team
Mahnoosh (Mona) Sharifi, MD, MPH
Principal Investigator
Yale University
Eligibility Criteria
This trial is for children aged 8-12 with severe obesity (BMI ≥95th percentile) and their parents. It's not for kids who've had eating disorders, dramatic weight loss, are in another similar study or program, planning bariatric surgery soon, have conditions affecting eating or exercise abilities, cognitive impairments, or language barriers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants engage in the Bright Bodies program aimed at improving BMI and health behaviors
Follow-up
Participants are monitored for changes in BMI and health behaviors after the intervention
Treatment Details
Interventions
- Bright Bodies
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator